Health and Fitness Health and Fitness
Thu, December 4, 2008
Wed, December 3, 2008

Somaxon Pharmaceuticals to Present at the RBC Capital Markets Healthcare Conference


Published on 2008-12-03 08:07:49 - Market Wire
  Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard Pascoe, president and chief executive officer, will participate in a panel discussion at the RBC Capital Markets Healthcare Conference at the Westin Times Square Hotel in New York, on Wednesday, December 10, 2008 at 2:30 p.m. ET (11:30 a.m. PT).

A live webcast of the presentation will be available in the Investor Relations section of the company's website under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for at least 14 days.

About Somaxon Pharmaceuticals

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. A New Drug Application (NDA) for Silenor® (doxepin), Somaxon's drug candidate for insomnia, has been filed with the U.S. Food and Drug Administration and currently is under review.

For more information, please visit the company's web site at [ www.somaxon.com ].

Similar Health and Fitness Articles